A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation

Mullane, Kathleen M; Winston, Drew J; Nooka, Ajay; Morris, Michele I; Stiff, Patrick; Dugan, Michael J; Holland, Henry; Gregg, Kevin; Adachi, Javier A; Pergam, Steven A; Alexander, Barbara D; Dubberke, Erik R; Broyde, Natalya; Gorbach, Sherwood L; Sears, Pamela S

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation

Clicks: 203

ID: 115564

2019

Patients undergoing hematopoietic stem cell transplantation are at elevated risk for development of Clostridium difficile–associated diarrhea (CDAD). Fidaxomici

Reference Key	m2019clinicala Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors	Mullane, Kathleen M;Winston, Drew J;Nooka, Ajay;Morris, Michele I;Stiff, Patrick;Dugan, Michael J;Holland, Henry;Gregg, Kevin;Adachi, Javier A;Pergam, Steven A;Alexander, Barbara D;Dubberke, Erik R;Broyde, Natalya;Gorbach, Sherwood L;Sears, Pamela S;
Journal	clinical infectious diseases
Year	2019
DOI	DOI not found
URL	https://academic.oup.com/cid/article/68/2/196/5035214?searchresult=1#supplementary-data
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

Login to comment Register

No comments yet. Be the first to comment on this article.